A national survey of people living with a neurological condition, including multiple sclerosis, launches today. The Neurological Alliance, representing 80 organisations working across England to improve life for people living with a neurological condition, is running their second neurological patient experience survey.
The Thames Valley Strategic Clinical Network launches a new report calling for improvements in neurological services provided in the community.
Results from two trials of an aggressive form of stem cell therapy indicate the treatment may have long-term benefits.
Preliminary results announced in a company press release report that opicinumab (also known as anti-LINGO-1 and BIIB033) failed to improve disability, assessed by a combination of physical and cognitive measures.
Researchers in Canada have identified a gene that appears to significantly increase the risk of developing a rare rapidly progressing form of MS.